These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25800824)

  • 21. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells.
    Zhou B; Yang Z; Feng Q; Liang X; Li J; Zanin M; Jiang Z; Zhong N
    J Ethnopharmacol; 2017 Mar; 199():60-67. PubMed ID: 28119097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
    Ma Q; Huang W; Zhao J; Yang Z
    J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.
    Geiler J; Michaelis M; Naczk P; Leutz A; Langer K; Doerr HW; Cinatl J
    Biochem Pharmacol; 2010 Feb; 79(3):413-20. PubMed ID: 19732754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection of human retinal pigment epithelial cells with influenza A viruses.
    Michaelis M; Geiler J; Klassert D; Doerr HW; Cinatl J
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5419-25. PubMed ID: 19553611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saikosaponin A inhibits influenza A virus replication and lung immunopathology.
    Chen J; Duan M; Zhao Y; Ling F; Xiao K; Li Q; Li B; Lu C; Qi W; Zeng Z; Liao M; Liu Y; Chen W
    Oncotarget; 2015 Dec; 6(40):42541-56. PubMed ID: 26637810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes.
    Mühlbauer D; Dzieciolowski J; Hardt M; Hocke A; Schierhorn KL; Mostafa A; Müller C; Wisskirchen C; Herold S; Wolff T; Ziebuhr J; Pleschka S
    J Virol; 2015 Jun; 89(11):6009-21. PubMed ID: 25810542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
    Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
    Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro.
    Li Z; Li L; Zhou H; Zeng L; Chen T; Chen Q; Zhou B; Wang Y; Chen Q; Hu P; Yang Z
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear export of influenza viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral matrix protein.
    Sakaguchi A; Hirayama E; Hiraki A; Ishida Y; Kim J
    Virology; 2003 Feb; 306(2):244-53. PubMed ID: 12642098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of fluvastatin on influenza virus infection.
    Peng J; Zhang D; Ma Y; Wang G; Guo Z; Lu J
    Mol Med Rep; 2014 Jun; 9(6):2221-6. PubMed ID: 24676773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human H7N9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H7N9 virus.
    To KK; Lau CC; Woo PC; Lau SK; Chan JF; Chan KH; Zhang AJ; Chen H; Yuen KY
    Virol J; 2016 Mar; 13():42. PubMed ID: 26975414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pterodontic Acid Isolated from Laggera pterodonta Inhibits Viral Replication and Inflammation Induced by Influenza A Virus.
    Guan W; Li J; Chen Q; Jiang Z; Zhang R; Wang X; Yang Z; Pan X
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29035328
    [No Abstract]   [Full Text] [Related]  

  • 34. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function.
    Ding Y; Zeng L; Li R; Chen Q; Zhou B; Chen Q; Cheng PL; Yutao W; Zheng J; Yang Z; Zhang F
    BMC Complement Altern Med; 2017 Feb; 17(1):130. PubMed ID: 28235408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein.
    Zhang J; Huang F; Tan L; Bai C; Chen B; Liu J; Liang J; Liu C; Zhang S; Lu G; Chen Y; Zhang H
    J Virol; 2016 Apr; 90(8):3966-3980. PubMed ID: 26842467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.
    Schräder T; Dudek SE; Schreiber A; Ehrhardt C; Planz O; Ludwig S
    Antiviral Res; 2018 Sep; 157():80-92. PubMed ID: 29990517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening.
    Zhang J; Liu T; Tong X; Li G; Yan J; Ye X
    Antiviral Res; 2012 Jan; 93(1):48-54. PubMed ID: 22057306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
    Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
    Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
    Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.